AMCP Names Mason Johnson 2022–2023 Executive Fellow in Health Care Association Leadership

AMCP applauds the House reintroduction of the Medicaid VBPs for Patients (MVP) Act (H.R. 7871) by Rep. Brett Guthrie (KY-02) alongside Rep. Jake Auchincloss (MA-04), Rep. Mariannette Miller-Meeks (IA-01), Rep. John Joyce (PA-13), Rep. Scott Peters (CA-50), and Rep. Don Davis (NC-01). This bipartisan legislation complements Senate bill S. 1637 and aims to improve patient access to novel therapies by enhancing the use of value-based purchasing arrangements in Medicaid.

The AMCP Research Institute announced the launch of a new medication therapy management (MTM) health care improvement initiative designed to assess and manage modifiable risk factors for dementia in asymptomatic, middle-aged adults. The initiative is supported by a generous grant from Lilly and aims to address critical gaps in the identification and intervention of early dementia risk.

The Academy of Managed Care Pharmacy (AMCP), in partnership with the AMCP Research Institute, published the 2025 edition of its annual Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy report, which provides an in-depth look at how managed care pharmacy practices improve patient health outcomes, control prescription drug spending, and promote affordability for millions of Americans.